pcDNA3 mHIF-2α MYC (P405A/P530V/N851A) Citations (5)

Originally described in: The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha.
Hu CJ, Sataur A, Wang L, Chen H, Simon MC Mol Biol Cell. 2007 Nov;18(11):4528-42. Epub 2007 Sep 5. PubMed Journal

---

Articles Citing pcDNA3 mHIF-2α MYC (P405A/P530V/N851A)

Articles
Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade. Gu YF, Cohn S, Christie A, McKenzie T, Wolff N, Do QN, Madhuranthakam AJ, Pedrosa I, Wang T, Dey A, Busslinger M, Xie XJ, Hammer RE, McKay RM, Kapur P, Brugarolas J. Cancer Discov. 2017 Aug;7(8):900-917. doi: 10.1158/2159-8290.CD-17-0292. Epub 2017 May 4. PubMed
Transient HIF2A inhibition promotes satellite cell proliferation and muscle regeneration. Xie L, Yin A, Nichenko AS, Beedle AM, Call JA, Yin H. J Clin Invest. 2018 Jun 1;128(6):2339-2355. doi: 10.1172/JCI96208. Epub 2018 Apr 30. PubMed
Hypoxia Activates the PTHrP -MEF2C Pathway to Attenuate Hypertrophy in Mesenchymal Stem Cell Derived Cartilage. Browe DC, Coleman CM, Barry FP, Elliman SJ. Sci Rep. 2019 Sep 16;9(1):13274. doi: 10.1038/s41598-019-49499-x. PubMed
The transcriptional coregulator CITED2 suppresses expression of IRS-2 and impairs insulin signaling in endothelial cells. Kunkemoeller B, Chen K, Lockhart SM, Wang X, Rask-Madsen C. Am J Physiol Endocrinol Metab. 2021 Aug 1;321(2):E252-E259. doi: 10.1152/ajpendo.00435.2020. Epub 2021 Jun 21. PubMed
The BMAL1/HIF2A heterodimer modulates circadian variations of myocardial injury. Ruan W, Li T, Lee J, Bang IH, Deng W, Ma X, Yoo SH, Kim B, Li J, Yuan X, An YA, Wang YY, Liang Y, Deberge M, Zhang D, Zhou Z, Wang Y, Gorham J, Seidman JG, Seidman CE, Aranki SF, Nair R, Li L, Narula J, Zhao Z, Abebe AG, Muehlschlegel JD, Tsai KL, Eltzschig HK. Res Sq [Preprint]. 2024 Feb 28:rs.3.rs-3938716. doi: 10.21203/rs.3.rs-3938716/v1. PubMed

If you have published an article using this material, please email us at to have your article added to this page.